Olivia Bawa

1.7k total citations
31 papers, 879 citations indexed

About

Olivia Bawa is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Olivia Bawa has authored 31 papers receiving a total of 879 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 10 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Olivia Bawa's work include Immunotherapy and Immune Responses (4 papers), Neuroblastoma Research and Treatments (4 papers) and Prostate Cancer Treatment and Research (4 papers). Olivia Bawa is often cited by papers focused on Immunotherapy and Immune Responses (4 papers), Neuroblastoma Research and Treatments (4 papers) and Prostate Cancer Treatment and Research (4 papers). Olivia Bawa collaborates with scholars based in France, United States and Italy. Olivia Bawa's co-authors include Paule Opolon, Thiérry Heidmann, Gérard Pierron, Cécile Vernochet, Anne Dupressoír, Francis Harper, Estelle Daudigeos‐Dubus, Birgit Geoerger, Gilles Vassal and Odile Heidmann and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Advanced Materials and Blood.

In The Last Decade

Olivia Bawa

30 papers receiving 872 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olivia Bawa France 17 441 189 159 133 131 31 879
Tim Coorens United Kingdom 17 550 1.2× 122 0.6× 84 0.5× 40 0.3× 210 1.6× 31 953
Andy J.G. Pötgens Germany 21 646 1.5× 113 0.6× 269 1.7× 56 0.4× 121 0.9× 25 1.1k
Rurika Oka Netherlands 15 800 1.8× 233 1.2× 82 0.5× 282 2.1× 251 1.9× 23 1.3k
Jose Espejo Valle-Inclán United Kingdom 13 561 1.3× 272 1.4× 72 0.5× 107 0.8× 197 1.5× 17 982
Joseph F. Boland United States 21 551 1.2× 171 0.9× 113 0.7× 24 0.2× 151 1.2× 35 1.2k
Anna Szeles Sweden 21 1.0k 2.3× 359 1.9× 306 1.9× 145 1.1× 256 2.0× 33 1.5k
Anna Morena D’Alise Italy 19 866 2.0× 464 2.5× 592 3.7× 88 0.7× 349 2.7× 42 1.7k
T. Tao United States 22 700 1.6× 160 0.8× 342 2.2× 30 0.2× 214 1.6× 45 1.2k
Gaël A. Millot France 20 1.0k 2.3× 188 1.0× 232 1.5× 87 0.7× 443 3.4× 36 1.5k
Takashi Yugawa Japan 22 915 2.1× 477 2.5× 213 1.3× 47 0.4× 200 1.5× 39 1.5k

Countries citing papers authored by Olivia Bawa

Since Specialization
Citations

This map shows the geographic impact of Olivia Bawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivia Bawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivia Bawa more than expected).

Fields of papers citing papers by Olivia Bawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olivia Bawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivia Bawa. The network helps show where Olivia Bawa may publish in the future.

Co-authorship network of co-authors of Olivia Bawa

This figure shows the co-authorship network connecting the top 25 collaborators of Olivia Bawa. A scholar is included among the top collaborators of Olivia Bawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olivia Bawa. Olivia Bawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gonnelli, Alessandra, Maria Laura Ermini, Nicolas Signolle, et al.. (2024). Nonpersistent Nanoarchitectures Enhance Concurrent Chemoradiotherapy in an Immunocompetent Orthotopic Model of HPV+ Head/Neck Carcinoma. Advanced Materials. 36(28). e2400949–e2400949. 8 indexed citations
2.
Fretellier, Nathalie, Miguel Luz Soares, Robin Santus, et al.. (2024). Antitumoral effect of local injection of TLR-9 agonist emulsified in Lipiodol with systemic anti-PD-1 in a murine model of colorectal carcinoma. Frontiers in Immunology. 14. 1272246–1272246. 1 indexed citations
3.
Durand, Sylvère, Olivia Bawa, Mélanie Bourgin, et al.. (2024). Biomarker Identification in Liver Cancers Using Desorption Electrospray Ionization Mass Spectrometry (DESI-MS) Imaging: An Approach for Spatially Resolved Metabolomics. Methods in molecular biology. 2769. 199–209. 2 indexed citations
4.
Hamon, Pauline, Marion Classe, Nicolas Signolle, et al.. (2022). TGFβ receptor inhibition unleashes interferon-β production by tumor-associated macrophages and enhances radiotherapy efficacy. Journal for ImmunoTherapy of Cancer. 10(3). e003519–e003519. 26 indexed citations
5.
Pawlikowska, Patrycja, Marianne Oulhen, Vincent Faugeroux, et al.. (2020). Exploitation of the chick embryo chorioallantoic membrane (CAM) as a platform for anti-metastatic drug testing. Scientific Reports. 10(1). 16876–16876. 46 indexed citations
6.
Costa, Maria Eugénia Marques Da, et al.. (2019). MT2A is an early predictive biomarker of response to chemotherapy and a potential therapeutic target in osteosarcoma. Scientific Reports. 9(1). 12301–12301. 16 indexed citations
7.
Costa, Maria Eugénia Marques Da, Estelle Daudigeos‐Dubus, Anne Gomez‐Brouchet, et al.. (2018). Establishment and characterization of in vivo orthotopic bioluminescent xenograft models from human osteosarcoma cell lines in Swiss nude and NSG mice. Cancer Medicine. 7(3). 665–676. 12 indexed citations
8.
Rivera-Muñoz, Paola, Aurélie Siret, Cécile K. Lopez, et al.. (2018). Partial trisomy 21 contributes to T-cell malignancies induced by JAK3-activating mutations in murine models. Blood Advances. 2(13). 1616–1627. 10 indexed citations
9.
Maisonial‐Besset, Aurélie, Isabelle Navarro‐Teulon, Odile Berthier‐Vergnes, et al.. (2017). Tetraspanin 8 (TSPAN 8) as a potential target for radio-immunotherapy of colorectal cancer. Oncotarget. 8(13). 22034–22047. 25 indexed citations
10.
Daudigeos‐Dubus, Estelle, Ludivine Le Dret, Olivia Bawa, et al.. (2016). Dual inhibition using cabozantinib overcomes HGF/MET signaling mediated resistance to pan-VEGFR inhibition in orthotopic and metastatic neuroblastoma tumors. International Journal of Oncology. 50(1). 203–211. 31 indexed citations
11.
Daudigeos‐Dubus, Estelle, Ludivine Le Dret, Claudia Lanvers‐Kaminsky, et al.. (2015). Regorafenib: Antitumor Activity upon Mono and Combination Therapy in Preclinical Pediatric Malignancy Models. PLoS ONE. 10(11). e0142612–e0142612. 37 indexed citations
12.
Antony‐Debré, Iléana, Nathalie Balayn, Dominique Bluteau, et al.. (2014). Level of RUNX1 activity is critical for leukemic predisposition but not for thrombocytopenia. Blood. 125(6). 930–940. 71 indexed citations
13.
Vilalta, Marta, et al.. (2014). Cyr61 silencing reduces vascularization and dissemination of osteosarcoma tumors. Oncogene. 34(24). 3207–3213. 21 indexed citations
14.
Greco, Céline, Yingying Zhu, Martine Billard, et al.. (2014). Effect of an anti-human Co-029/tspan8 mouse monoclonal antibody on tumor growth in a nude mouse model. Frontiers in Physiology. 5. 364–364. 33 indexed citations
15.
Patel, Satyananda, M. Wittner, Christophe Willekens, et al.. (2012). CXCR4 inhibitors selectively eliminate CXCR4-expressing human acute myeloid leukemia cells in NOG mouse model. Cell Death and Disease. 3(10). e396–e396. 52 indexed citations
16.
Leguerney, Ingrid, Nathalie Lassau, Serge Koscielny, et al.. (2010). Combining functional imaging and interstitial pressure measurements to evaluate two anti-angiogenic treatments. Investigational New Drugs. 30(1). 144–156. 11 indexed citations
17.
Nakouzi, Nader Al, Paule Opolon, Olivia Bawa, et al.. (2010). Abstract 4339: Prostate adenocarcinoma and intensive bone remodeling in a new prostate cancer IGR-CaP1 preclinical model derived from a human primary tumor. Cancer Research. 70(8_Supplement). 4339–4339. 1 indexed citations
18.
Bielawska‐Pohl, Aleksandra, Séverine Blesson, Houssem Benlalam, et al.. (2010). The anti-angiogenic activity of IL-12 is increased in iNOS−/− mice and involves NK cells. Journal of Molecular Medicine. 88(8). 775–784. 17 indexed citations
19.
Dupressoír, Anne, Cécile Vernochet, Olivia Bawa, et al.. (2009). Syncytin-A knockout mice demonstrate the critical role in placentation of a fusogenic, endogenous retrovirus-derived, envelope gene. Proceedings of the National Academy of Sciences. 106(29). 12127–12132. 260 indexed citations
20.
Bouclier, Céline, Véronique Marsaud, Olivia Bawa, et al.. (2009). Coadministration of nanosystems of short silencing RNAs targeting oestrogen receptor α and anti-oestrogen synergistically induces tumour growth inhibition in human breast cancer xenografts. Breast Cancer Research and Treatment. 122(1). 145–158. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026